A Randomized Trial Assessing the Safety, Pharmacokinetics, and Efficacy During Morning Off of AZ-009.
Eva ThijssenJonas M den HeijerDavid PuibertLaurence MossMingzu LeiDavid HasegawaKyo KeumKen MochelMohammed Ezzeldin SharafTom AlfredsonWenxiang ZengEmilie van BrummelenTatjana NarandaGeert Jan GroeneveldPublished in: Movement disorders : official journal of the Movement Disorder Society (2022)
AZ-009 appears to be a rapid-acting and reasonably well-tolerated formulation for treating off periods. © 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.